M&A highlights from previous weeks…👇
YTD Summary:
Number Announced: 30
Q1 2024 # Announced: 18
Q2 2024 # Announced: 12
Proteologix
Acquired By: Johnson & Johnson
Announcement Date: May 16, 2024
Acquisition Price: $850M + potential milestone payment
Acquisition Date (Closed): Pending
Lead Asset: PX128
Lead Asset Stage: Phase 1
Indication: Atopic dermatitis and Asthma
Reneo Pharmaceuticals & OnKure (Merger)
Announcement Date: May 13, 2024
Merger Date (Closed): Pending
Lead Asset: OKI-219
Lead Asset Stage: Phase 1
Lead Asset Indication: Solid tumors
Mariana Oncology
Acquired By: Novartis
Announcement Date: May 2, 2024
Acquisition Price: $1B + up to $750M milestone payments
Acquisition Date (Closed): Pending
Lead Asset: MC-339
Lead Asset Stage: Preclinical
Lead Asset Indication: Small cell lung cancer
---
Get a list of all recently funded companies with deeper info to help your sales/BD activities. Contact us to learn more
Article History:
RF, DV, DG (05/16/24)
This article is not investment or legal advice.
Comentarios